Diversity in Clinical Trials
Description
The diversity of participants in a clinical trial should reflect that of our society and/or the populations affected by the studied disease(s). This session will review disparities in clinical research as well as provide ways to increase clinical trial enrollment amongst underrepresented communities.
Learning Objectives
- How patients access clinical trials
- Disparities in clinical research
- Ways to increase clinical trial enrollment amongst underrepresented populations
Target Audience
Physicians, medical directors, social workers
Speakers
- Mark Fleury, PhD, American Cancer Society Cancer Action Network
- Brenna O'Brien, Clinical Trials Navigator, NMDP